The role of induction therapy in the management of resectable non-small cell lung cancer

Cancer Control

Volumn 7, Issue 1, 2000, Pages 45-55

  Hensing, Thomas A ^a   Detterbeck, Frank ^a   Socinski, Mark A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; MITOMYCIN; PACLITAXEL; VINBLASTINE; VINCRISTINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL RESEARCH; DRUG INDUCED DISEASE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MEDICAL LITERATURE; MULTIMODALITY CANCER THERAPY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0033952612     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480000700104     Document Type: Article

References (53)